載入...
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
BACKGROUND AND AIM: In December 2019, the first cases of SARS-CoV-2 infection were detected in Wuhan. Within two months, it had begun to spread around the world in what became an unprecedented pandemic. Patients with Multiple Sclerosis (MS) in a state of immunosuppression may be considered at risk f...
Na minha lista:
| 發表在: | Mult Scler Relat Disord |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier B.V.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7295509/ https://ncbi.nlm.nih.gov/pubmed/32585617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102306 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|